Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | ACHE | P22303 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26414339 | 0.93 | L3MBTL1 (0.52) | NPSR1L3MBTL1LMNAPKMALDH1A1 | |
| Formic Acid SCHEMBL30219804 | 0.80 | NPSR1 (0.48) | NPSR1L3MBTL1LMNAALDH1A1ACHE | |
| SCHEMBL28949219 | 0.79 | L3MBTL1 (0.43) | NPSR1L3MBTL1ALDH1A1HPGDKDM4E | |
| SCHEMBL11509120 | 0.78 | L3MBTL1 (0.58) | NPSR1L3MBTL1LMNAALDH1A1ACHE | |
| SCHEMBL23351211 | 0.77 | PKM (0.40) | NPSR1L3MBTL1LMNAPKMALDH1A1 | |
| SCHEMBL26497835 | 0.77 | CYP4F2 (0.53) | LMNAPKMALDH1A1ACHEHPGD | |
| Trifluoroacetic Acid SCHEMBL30320101 | 0.76 | PDK2 (0.36) | NPSR1L3MBTL1LMNAALDH1A1ACHE | |
| Hydrochloric Acid SCHEMBL11510418 | 0.75 | NPSR1 (0.58) | NPSR1L3MBTL1LMNAALDH1A1ACHE | |
| Hydrochloric Acid SCHEMBL29902133 | 0.75 | LMNA (0.59) | NPSR1L3MBTL1LMNAALDH1A1ACHE | |
| Hydrochloric Acid SCHEMBL17907273 | 0.75 | LMNA (0.59) | NPSR1L3MBTL1LMNAALDH1A1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4153565-B1 | BENZYLPYRIDINIUM REAGENT FOR MASS SPECTROMETRY | HOFFMANN LA ROCHE (CH) | 2026-02-18 | — | — | EP | disclosed |
| US-12424426-B2 | Benzylpyridinium reagent for mass spectrometry | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2025-09-23 | — | — | US | disclosed |
| US-20230127289-A1 | BENZYLPYRIDINIUM REAGENT FOR MASS SPECTROMETRY | ROCHE DIAGNOSTICS GMBH (DE) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230127289-A1 | BENZYLPYRIDINIUM REAGENT FOR MASS SPECTROMETRY | SRMS, PTMS, BRD4 | NPSR1 2660/4885L3MBTL1 1054/4885LMNA 1187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.